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Role of Alginates Combined with 
Natural Extracts to Prevent the 
Gastric Acid-Related Damage
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Mietta Catera and Claudio Molinari
Abstract
The human stomach is extremely vulnerable to various attacks able to cause 
erosion and mucosal epithelium damage which lead to gastrointestinal tract bleed-
ing and/or ulcer perforations and finally worsen the original disease. A prolonged 
exposition to strong acidic environment causes coagulation necrosis resulting from 
the desiccating action of the acid on proteins in exposed tissues with inflammation 
and accumulation of intracellular radical oxygen species. Therapeutic strategies 
aim to treat both symptoms and epithelial damage with chemical or mechanical 
approaches. In this context, alginates seem to have great importance, especially if 
combined with other molecules known to have some properties on gastric epithelial 
cells, for example, vitamin D3, extract of prickly pear and olive leaves, and a tyndal-
ized probiotic. This natural composition is able to exert a gastroprotective effect 
to maintain or restore the integrity of gastric epithelium through an antioxidant 
pathway, inhibiting apoptosis and activating survival kinases better than other 
pharmacological or natural active principles.
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1. Introduction
The impact of gastric diseases on human health is a worldwide problem in 
modern society [1, 2]. For example, in the USA, studies have reported gastroin-
testinal illness rates in the range of 0.5–2 episodes/year/person and incidence of 
5–100 episodes/1000/week according to seasons and age. The number of episodes 
of gastrointestinal illnesses is similar in both 40-year-old studies and in recent 
ones [3, 4]. The gastrointestinal disorder, including chronic gastritis, duodenal 
and gastric ulceration, adenocarcinoma, and gastric mucosa-associated lymphoid 
tissue (MALT), may have a common cause which is gastroesophageal reflux disease 
(GERD). The cardinal symptom is heartburn caused by the involuntary move-
ment of gastric contents to the esophagus that occurs several times a day, mainly in 
postprandial period [5]. In particular, most reflux episodes are of short duration, 
asymptomatic, and limited to the distal esophagus [6]. However, some episodes 
occur with typical symptoms such as burning sensation in the chest that can also 
extend to the throat, gastric pain, episodes of regurgitation, dysphagia, and sen-
sation of bolus in the throat [7]. One of the risk factors is bad eating habits that 
Alginates - Recent Uses of This Natural Polymer
2
can aggravate gastroesophageal reflux and can contribute to the delayed gastric 
emptying with an increase of acid secretion in the stomach [8]. In the human 
stomach, the acid environment (pH 1 to 2) acts both as a primary defense against 
infections and intervenes in the early stages of digestion [9]. The gastrointestinal 
epithelium is a fundamental barrier protecting the gastrointestinal mucosa from 
damage through the ability of epithelial cells to spread and migrate across the 
basement membrane to repair the damage [4]. However, gastric acid (HCl) secreted 
from gastric parietal cells has been reported to determine gastric mucosal injuries, 
and, consequently, a prolonged exposition to strong acidic environment causes 
coagulation necrosis in exposed tissues [10]. A mild gastritis condition can cause 
long-lasting damage resulting in cellular injury which in turn causes inflammation 
[11] that creates further free radical-dependent tissue destruction [12, 13]. This 
injury involves DNA and can lead to stomach cancer genesis [14]. Some recent 
studies have shown that non-steroidal anti-inflammatory drugs (NSAIDs) are one 
of the most common causes of damage on the gastric mucosa through the produc-
tion of free oxygen radicals (ROS) leading to lipid peroxidation and apoptosis [10, 
15] of cells. In particular, superoxide anion (O−2) produced by mitochondria is the 
main cause of oxidative damage [16] and plays a critical role in the pathogenesis of 
gastric disorders [17]. Around 30 million people consume NSAIDs globally every 
day [18] since they are prescribed because of their efficacy in the management of 
pain, inflammation, and fever [19]. Adverse effects associated with NSAIDs, such as 
alterations in renal function, effects on blood pressure, hepatic injury, and platelet 
inhibition, are a challenge in clinical treatment optimization [20]. However, gastric 
mucosal perforation and bleeding are a major concern as well as the worst outcome 
of prolonged NSAID therapy [21]. NSAIDs are able to induce gastric mucosal lesions 
because of their acidic properties [22]. The mechanism behind gastric damage 
involves a highly acidic gastric environment that favors the migration of nonion-
ized lipophilic NSAIDs into the epithelial cells [23]. Diclofenac is the most widely 
prescribed NSAID for treating pain, inflammation, and several forms of cancer [24, 
25]. The main clinical problem exerted by diclofenac is toxicity related to oxidative 
injury of tissues, which appears to play a role in the pathophysiology of digestive 
tract ulceration [18, 25, 26]. For this reason, in order to prevent the damage, NSAID 
treatments are usually associated to proton-pump inhibitors (PPI) [27]. However, 
the anatomical and functional integrity of gastric mucosa rely on the balance 
between aggressive and defensive mechanisms [19]; for this reason, the success of 
pharmacological treatments in prevention or healing of gastric lesions depends both 
on the blockade of acid secretion and on the enhancement of mucosal protective 
factors [19]. In addition, current evidence suggests that PPI are also associated with 
numerous side effects such as hypergastrinemia, enteric infections, adverse car-
diovascular events, and increased mortality rates [23]. Basing on these data, it can 
therefore be assumed that gastric acid can induce ROS production, lipid peroxida-
tion, and apoptosis through a mechanism similar to that observed by NSAIDs 
[10]. For this reason, ROS, including H2O2, are a major cause of cellular oxidative 
damage [16], and they play a critical role in the pathogenesis of gastric disorders 
[2, 17]. After a gastric mucosa damage, several events occur in order to restore the 
integrity of the layer; normal epithelial repair consists of restitution of functions 
and regeneration of anatomical integrity involving epithelial proliferation followed 
by a remodeling phase [28]. During restitution, epithelial cells spread through the 
basement membrane to restore cell continuity, a process that is independent of cell 
proliferation. The clinical need to prevent or restore the damage of gastric mucosa 
in early stage encourages the search of novel agents able to counteract both the 
adverse effects of drugs and hyperacidic conditions with a better safety profile, 
in particular using natural compounds. A new group of widely used molecules 
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includes alginates, a polymer of alginic acid derived from the cell wall of various 
brown algae. Alginate-based compounds have been available for several decades 
[29] and are listed as inactive ingredients with a substantial and independent 
benefit from alginate formulation [29]. Recently, there is a new growing interest 
in alginates as a therapy for GERD, including patients with continued symptoms 
despite acid suppression therapy [30]. Alginates are polysaccharides composed 
of two β-d-mannuronic acid (M) and α-1-glucuronic acid (G) monomers which 
are held together by β 1,4 bonds; these monomers are not organized in repeated 
units, and they can be considered as a set of heterogeneous molecules since they are 
distributed as several different repetitions called M, G, or MG blocks [31, 32]. These 
alginates are able to block the HCl reflux in a mechanic manner; indeed, they do not 
have any pharmacologic property [33]. The mechanism of action of alginates has 
been called “rafting”, which means that in the presence of gastric acid, they form a 
gel in which carbon dioxide (resulting from the splitting of bicarbonate) is trapped. 
Then the gel is carried to the top of the gastric contents neutralizing the acidity and 
preventing the ascent of acid material into the esophagus [34]. The advantage of 
alginate-based reflux suppressants over antacid alone is that they provide rapid and 
longer-lasting symptom relief [35].
Subsequently, it was seen that it is useful to associate alginates with natural 
substances. This association has been found to be effective in promoting stomach 
health, reducing inflammation, and supporting the immune system. Zinc, a 
micronutrient involved in multiple functions, is able to act as a coenzyme on several 
enzymes that protect cells against free radical damage [36]. Furthermore, zinc has 
direct effects against inflammation, as it helps to stabilize the membrane of mast 
cells, responsible for inflammation [37]. Other natural products with antioxidant 
property seem to play an active role in the stomach well-being, such as blueberries 
or licorice, that they are able to reduce the production of cytokines and at the same 
time to increase the production of the mucous membrane of the stomach [38]. 
Moreover alginate/antacid system has been used as a carrier of probiotic, drugs, and 
plant extracts [39]. For example, alginate/bicarbonate combined with two herbal 
gastroprotective extracts (Opuntia ficus-indica and Olea europaea) has been success-
fully evaluated in patients with GERD [39]. However, the most common treat-
ments for gastroesophageal reflux includes different molecules such as magnesium 
hydroxide or aluminum hydroxide (commercially named Maalox®) in which they 
absorb gastric acidity, reducing the pH and reducing/reversibly blocking acid secre-
tion by parietal cells. The effectiveness of these preparations is due to their ability to 
exert a buffering effect on the gastric pH [40], but the adverse effect is that they can 
cause an accumulation of aluminum which is a common cause of neurodegenera-
tion and neurotoxicity [40].
Recent studies have explored a possible role of vitamin D3, the active form of 
vitamin D, on gastroprotection as one of the extra skeletal effects this vitamin has 
[4, 23]. Vitamin D3 binds its receptor VDR which is present in several tissue targets 
in the digestive system, in particular in the oral region, and in epithelial cells of the 
oral cavity, tongue, and gums. In addition, vitamin D3 appears to have a therapeutic 
role in gastric mucosa as well, stimulating cell proliferation and differentiation [41] 
and regulating endocrine/paracrine gastrin and pepsinogen secretions [42]. Finally, 
vitamin D3 acts on smooth muscle cells in the pyloric region and in different areas of 
the small intestine [42]. Furthermore, the low plasmatic level of vitamin D3 is found 
to be responsible for an insufficient emptying of the stomach, swelling, constipation, 
and intestinal irritation [42]. After the binding between vitamin D3 and its recep-
tor, several intracellular events involved in different mechanism start, including the 
protective role against oxidative stress [43], the regulation of autophagic pathways 
through the regulation of ATG16L1, a protein complex necessary for autophagy [44], 
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and the ability to inhibit apoptosis by increasing the expression of endothelial 
nitric oxide synthase (eNOS) leading to the nitric oxide (NO) production [43]. In 
this context, vitamin D3 can exert some beneficial effects on gastric tissue. For this 
reason, its use in association with other gastroprotective agents such as alginates can 
increase therapeutic efficacy of the formulation in respect to the efficacy that would 
be obtained only with gastroprotective drugs. Indeed, this effect is described in a 
recent study in which this association (vitamin D3 and raft-forming alginates, buf-
fers, polysaccharides, and biophenols named Aquilea Reflux®) could be of greater 
efficacy when compared to other gastroprotectants (e.g., Maalox® or Gaviscon®) 
or other natural extracts (e.g., Neobianacid®) [4, 23]. Aquilea Reflux® is a dietary 
supplement that combines the properties of calcium alginate in a buffer solution, 
resulting from alkaline salts useful to counteract situations of high acidity, with a 
tyndalized probiotic (Pylopass®) and an extract of prickly pear and olive leaves 
(Mucosave®). The extract of prickly pear is useful for its emollient and soothing 
characteristics at the level of the digestive system. All these agents were added to 
vitamin D3. This study demonstrates for the first time that the combination between 
alginate-based gastroprotector agent and vitamin D3 has a beneficial effect joining the 
effects of a mechanical barrier with the modulation of intracellular pathways in order 
to maintain or restore the integrity of gastric epithelium. Indeed, Aquilea Reflux® 
is able to improve the adhesivity of cells which is crucial on cell migration involving 
two important extracellular matrix glycoproteins, vitronectin and fibronectin. This is 
more important because it indicates that vitamin D3 is able to improve the beneficial 
effects induced by alginates, thus supporting data about the mechanism of gastropro-
tection induced by alginates [45]. Another important element is a time of adhesion, 
which is an important reparative event; the combination is able to occur rapidly, 
confirming other data about the reparative events following acute gastric injury [46]. 
Since there is evidence that oxidative stress plays an important role in the pathogen-
esis of acute gastric injury [47–49], Aquilea Reflux® has been also tested to verify if it 
is able to improve both cell viability and cell proliferation after H2O2 or HCl exposure. 
This combination significantly reduced ROS production and decreased cell viability 
loss, suggesting that cell damage and cytotoxicity can be reduced.
These results suggest that it may exert a better gastroprotective effect through 
an antioxidant pathway, inhibiting apoptosis and activating survival kinases. Such 
effect was stronger in preventing epithelial damage than what was observed using 
other gastroprotective agents such as Gaviscon®, Maalox®, or proton-pump 
inhibitors. Ultimately, it can be said that alginate-based gastroprotectors combined 
with vitamin D3 have beneficial properties on gastric epithelial cells, joining the 
effects of a mechanical barrier with the modulation of intracellular pathways 
in order to maintain or restore the integrity of gastric epithelium. In addition, 
comparing the activity to other natural products, such as Neobianacid® which is 
a mixture of polysaccharides and flavonoids able to improve the protection of the 
stomach and the esophagus thanks to the presence of Poliprotect® and a flavonoid 
fraction (Matricaria recutita and Glycyrrhiza glabra), the combination composed 
of alginates plus vitamin D3 appears to have significant effects. Indeed, this com-
bination significantly reduced ROS production and decreased cell viability loss 
after the injury, suggesting that cell damage and cytotoxicity can be prevented, 
exerting a better gastroprotective effect through an antioxidant pathway, inhibiting 
apoptosis, and activating survival kinases. Such effect was stronger in preventing 
epithelial damage than what was observed using other gastroprotective agents such 
as Neobianacid® (Figure 1).
These data show that it is possible to improve the beneficial effects of alginates 
by combining active ingredients that are capable of intervening at the cellular 
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level to improve viability and to reduce the production of ROS, from which 
significant damage to the gastric mucosa originates. The formulation called 
Aquilea Reflux®, with its combination of chemical, mechanical, and biological 
agents, has proven to be effective in preventing cellular alterations caused by 
NSAIDs in both acid and hyperacidic conditions, reducing ROS production and 
apoptotic mechanism, and increasing the activation of survival kinases and cell 
proliferation.
Figure 1. 
Effects of Aq and Neo alone and combined with diclofenac during acidic and hyperacidic conditions. In 
panel A cell viability and in panel B ROS production observed in gastric epithelial cells treated for 24 h. P= 
pantoprazole, D= diclofenac. The other abbreviations are similarly reported in the figure. Data are expressed as 
means ± SD (%) of five independent experiments normalized to control values. *p < 0.05 vs. control; **p < 0.05 
vs. HCl; φp < 0.05 vs. diclofenac; φφp < 0.05 vs. HCl + diclofenac; arrows indicate p < 0.05 between different 
groups.
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2. Conclusions
In conclusion it can be stated that the antacid and gastroesophageal reflux abili-
ties of alginate-based preparations could be significantly improved by combining 
natural extraction components and vitamin D3, providing an association of chemi-
cal, mechanical, and cellular action to achieve a complete protective effect.
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